| Literature DB >> 15102920 |
Ke Ning1, Lin Pei, Mingxia Liao, Baosong Liu, Yunzhou Zhang, Wen Jiang, John G Mielke, Lei Li, Yonghong Chen, Youssef H El-Hayek, Michael G Fehlings, Xia Zhang, Fang Liu, James Eubanks, Qi Wan.
Abstract
The tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a lipid and protein phosphatase. We report here that PTEN physically associates with the NR1 and NR2B subunits of NMDA receptors (NMDARs) in rat hippocampus. Downregulating the protein expression of PTEN inhibits the function of extrasynaptic NMDARs and decreases NMDAR surface expression, suggesting a crucial role for endogenous PTEN in the modulation of NMDAR-mediated neuronal function. Reducing PTEN expression also enhances Akt/Bad phosphorylation in hippocampal neurons. Importantly, suppressing lipid and protein phosphatase activity of PTEN, respectively, activates Akt and inhibits extrasynaptic NMDAR activity and thereby protects against ischemic neuronal death in vitro and in vivo. Thus, our study reveals a dual neuroprotective mechanism by which Akt/Bad and extrasynaptic NMDARs are regulated via downregulation of two distinct PTEN phosphatase activities and present the possibility of PTEN as a potential therapeutic target for stroke treatment.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15102920 PMCID: PMC6729419 DOI: 10.1523/JNEUROSCI.5449-03.2004
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167